
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded suppository containing nicotine tartrate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products containing nicotine are listed in lozenge, gum, patch and spray forms. It is also a component of FDA-approved kits.
Suppository bases differ, and the base used decides how USP <795> classifies the preparation for beyond-use dating. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Nicotine tartrate is a salt of nicotine, a nicotinic receptor agonist, that compounding pharmacies prepare as topical creams, nasal sprays and oral preparations by prescription.
Nicotine is the chief alkaloid in tobacco. It binds nicotinic cholinergic receptors at the autonomic ganglia, the adrenal medulla, neuromuscular junctions and in the brain, raising heart rate and blood pressure and, in people who are addicted, relieving craving and withdrawal. Nicotine tartrate is a water-soluble salt of nicotine used as a compounding ingredient. The manufactured products are all smoking cessation aids: over-the-counter gum, lozenges and patches, and one prescription-only form, Nicotrol NS nasal spray (Pharmacia & Upjohn), FDA-approved as an aid to smoking cessation for relief of nicotine withdrawal symptoms as part of a behavioral program; the prescription Nicotrol inhaler was discontinued in 2023. Prescribers may order nicotine compounded when they want a strength, vehicle or route, such as a transdermal cream or a flavor-free oral form, that no manufactured product offers. Compounded preparations are not FDA-approved and require a prescription.
The Nicotrol NS label carries no boxed warning but states that nicotine from any source can be toxic and addictive, and that dependence on the spray occurred in clinical trials, with some patients using it longer than recommended. Do not use nicotine if you are allergic to it. It is generally not used right after a heart attack, with serious arrhythmias or with severe or worsening angina; tell your prescriber about heart disease, high blood pressure, overactive thyroid, pheochromocytoma, insulin-treated diabetes, stomach ulcers, asthma, or kidney or liver disease. Quitting smoking changes how the body handles other drugs: caffeine, theophylline, some beta-blockers, insulin and certain antidepressants may need dose changes, so review your list with your prescriber or pharmacist. Nicotine may harm the fetus. It concentrates in breast milk, and lactation references are divided on nicotine replacement during nursing. Keep nicotine products away from children and pets; swallowed nicotine is a poisoning emergency. For a rapid heartbeat or irritation that persists, talk to your prescriber or pharmacist.
Nicotine is an agonist at nicotinic acetylcholine receptors; its cardiovascular effects include peripheral vasoconstriction, tachycardia and elevated blood pressure. Per the Nicotrol NS label, plasma protein binding is under 5 percent, hepatic metabolism yields more than 20 metabolites, all less active than nicotine, chiefly trans-3-hydroxycotinine and cotinine (cotinine half-life 15 to 20 hours), roughly 10 percent of absorbed drug is excreted unchanged in urine, and the apparent elimination half-life after nasal dosing is 1 to 2 hours. Clearance falls in moderate to severe renal impairment and in moderate hepatic impairment. Smoking cessation de-induces hepatic enzymes, so doses of acetaminophen, caffeine, imipramine, oxazepam, pentazocine, propranolol and theophylline may need reduction, and subcutaneous insulin absorption rises. Labeled indication: Nicotrol NS as a prescription aid to smoking cessation; gum, lozenge and patch are over-the-counter. Transdermal nicotine has been studied for active ulcerative colitis; a Cochrane review of trials using nicotine patches (McGrath 2004) found transdermal nicotine better than placebo for inducing remission, no advantage over prednisone or mesalamine, and more adverse events and withdrawals. Dosing and route are per prescriber. Monitor for dependence, cardiovascular symptoms and local irritation. Nicotine is not a controlled substance.
Wash your hands. If the suppository is soft, chill it in its wrapper in the refrigerator or under cool water for a few minutes, then unwrap it. For rectal use, coat the tip with a water-soluble lubricant (not petroleum jelly), lie on your side with your upper knee bent, and insert it pointed end first past the muscle at the opening. For vaginal use, lie on your back with knees bent and insert it as far as it comfortably goes, by finger or applicator; bedtime use limits leakage, and a panty liner protects clothing. Stay lying down about 15 minutes. Wash your hands.
Suppositories are nonaqueous, so under USP <795> they can carry a beyond-use date of up to 180 days at controlled room temperature or in the refrigerator when no other stability data apply. Storage depends on the base: fatty bases can soften at room temperature and may be labeled for the refrigerator, while polyethylene glycol bases usually do not need refrigeration. Keep them cool so they do not melt, and refrigerate them if your label says to.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository